dna-1903319_960_720

Small number of mutations driving most cancers

October 20, 2017
Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …

teva_copy

Teva under investigation over illegal rebate offers to Ontario pharmacies

October 20, 2017
Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone

Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …

celgene_building

Celgene drops $710m drug, shares nosedive 7%

October 20, 2017
Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …

donor_card

Worrying number of organ donations blocked by families

October 19, 2017
Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …

portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

lilly_entrance_web

Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership

October 19, 2017
Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …

georgescangos

Vir Biotech blasts out of the blocks, with $500m in bank

October 19, 2017
Medical Communications, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical

All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …

Novo’s diabetes treatment semaglutide gets unanimous FDA backing

October 19, 2017
Sales and Marketing Novo Nordisk, diabetes, semaglutide

Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …

gilead-sciences

Gilead gets FDA nod for revolutionary blood cancer treatment

October 19, 2017
Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical

Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …

shutterstock_212432119

First-ever study in the personalised treatment of rare cancers brings promising results

October 18, 2017
Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer

The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …

mit-ai-cancer-detection-01_0

Breakthrough AI able to identify 97% of breast cancer risk

October 18, 2017
Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …

Novartis sheds generics plant and 450 jobs amid pricing pressure

October 18, 2017
Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …

nhs_trees

New studies point to cracks forming in NHS services

October 18, 2017
Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …

J&J’s third quarter: The good and the bad

October 18, 2017
Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …

Allergan’s patent shield – The (Native) American dream?

October 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

  In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …

shutterstock_159488225

AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours

October 17, 2017
Manufacturing and Production, Research and Development AstraZeneca, Cancer, Chi-Med, lung cancer, pharma, savolitinib

AstraZeneca and its partner Hutchison China MedTech, also known as Chi-Med, have announced positive data for savolitinib in combination with …

peanuts

Peanut allergies? There’s a clinical trial looking to fix that

October 17, 2017
Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical

Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …

EMA responds to criticism of its cancer drug approvals

October 17, 2017
Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical

The EMA received a broadside just less than two week ago from a group of researchers that had studied data …

diabetes-777001_960_720

Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens

October 17, 2017
Manufacturing and Production, Medical Communications Nigeria, Sanofi, WHO, diabetes, pharma

Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million …

5440392565_4634fb9d24_z

Trump suggests he will declare opioid national emergency next week

October 17, 2017
Manufacturing and Production, Sales and Marketing President trump, Trump, biotech, drugs, pharma, pharmaceutical

Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a …

The Gateway to Local Adoption Series

Latest content